Elgethun Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.59M | Buy |
6,305
+142
| +2% | +$30.6K | 0.22% | 58 |
|
|
2026
Q1 | $1.34M | Sell |
6,163
-139
| -2% | -$30.8K | 0.22% | 54 |
|
|
2025
Q4 | $1.44M | Buy |
6,302
+146
| +2% | +$33.3K | 0.25% | 51 |
|
|
2025
Q3 | $1.46M | Sell |
6,156
-62
| -1% | -$12.6K | 0.27% | 49 |
|
|
2025
Q2 | $1.15M | Sell |
6,218
-282
| -4% | -$52.4K | 0.23% | 51 |
|
|
2025
Q1 | $1.36M | Sell |
6,500
-631
| -9% | -$123K | 0.3% | 46 |
|
|
2024
Q4 | $1.27M | Buy |
7,131
+20
| +0.3% | +$3.68K | 0.31% | 47 |
|
|
2024
Q3 | $1.4M | Buy |
7,111
+19
| +0.3% | +$3.55K | 0.33% | 45 |
|
|
2024
Q2 | $1.22M | Sell |
7,092
-153
| -2% | -$25.3K | 0.31% | 52 |
|
|
2024
Q1 | $1.3M | Buy |
7,245
+20
| +0.3% | +$3.45K | 0.33% | 51 |
|
|
2023
Q4 | $1.12M | Buy |
7,225
+251
| +4% | +$36.6K | 0.32% | 53 |
|
|
2023
Q3 | $1.04M | Buy |
6,974
+27
| +0.4% | +$3.96K | 0.31% | 55 |
|
|
2023
Q2 | $936K | Buy |
6,947
+28
| +0.4% | +$4.11K | 0.28% | 57 |
|
|
2023
Q1 | $1.1M | Buy |
6,919
+27
| +0.4% | +$4.13K | 0.35% | 55 |
|
|
2022
Q4 | $1.12M | Buy |
6,892
+33
| +0.5% | +$5.06K | 0.4% | 52 |
|
|
2022
Q3 | $920K | Buy |
6,859
+1,149
| +20% | +$165K | 0.37% | 51 |
|
|
2022
Q2 | $872K | Buy |
5,710
+40
| +0.7% | +$6.11K | 0.34% | 53 |
|
|
2022
Q1 | $919K | Buy |
5,670
+42
| +0.7% | +$6.1K | 0.31% | 52 |
|
|
2021
Q4 | $754K | Buy |
5,628
+47
| +0.8% | +$5.55K | 0.26% | 61 |
|
|
2021
Q3 | $602K | Buy |
5,581
+91
| +2% | +$10.4K | 0.21% | 64 |
|
|
2021
Q2 | $618K | Buy |
5,490
+46
| +0.8% | +$5.18K | 0.21% | 63 |
|
|
2021
Q1 | $589K | Buy |
5,444
+691
| +15% | +$73.9K | 0.23% | 59 |
|
|
2020
Q4 | $509K | Hold |
4,753
| – | – | 0.22% | 60 |
|
|
2020
Q3 | $416K | Hold |
4,753
| – | – | 0.23% | 58 |
|
|
2020
Q2 | $467K | Hold |
4,753
| – | – | 0.27% | 57 |
|
|
2020
Q1 | $362K | Hold |
4,753
| – | – | 0.2% | 64 |
|
|
2019
Q4 | $421K | Hold |
4,753
| – | – | 0.21% | 63 |
|
|
2019
Q3 | $354K | Hold |
4,753
| – | – | 0.19% | 65 |
|
|
2019
Q2 | $346K | Hold |
4,753
| – | – | 0.19% | 67 |
|
|
2019
Q1 | $383K | Hold |
4,753
| – | – | 0.22% | 67 |
|
|
2018
Q4 | $424K | Sell |
4,753
-84
| -2% | -$7.39K | 0.29% | 69 |
|
|
2018
Q3 | $461K | Sell |
4,837
-50
| -1% | -$4.74K | 0.3% | 67 |
|
|
2018
Q2 | $452K | Sell |
4,887
-325
| -6% | -$31.7K | 0.32% | 67 |
|
|
2018
Q1 | $493K | Hold |
5,212
| – | – | 0.34% | 68 |
|
|
2017
Q4 | $504K | Sell |
5,212
-230
| -4% | -$21.7K | 0.35% | 63 |
|
|
2017
Q3 | $484K | Hold |
5,442
| – | – | 0.36% | 60 |
|
|
2017
Q2 | $395K | Sell |
5,442
-117
| -2% | -$7.87K | 0.31% | 63 |
|
|
2017
Q1 | $362K | Sell |
5,559
-172
| -3% | -$10.8K | 0.29% | 64 |
|
|
2016
Q4 | $359K | Buy |
+5,731
| New | +$350K | 0.28% | 60 |
|
Other funds holding ABBV
ECSS
ATO
Elgethun Capital Management's ABBV Position: Q2 2026 in Review
Elgethun Capital Management increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $30.6K and bringing the position to 6,305 shares worth $1.59M. The position accounts for 0.22% of the portfolio, ranked #58.
Elgethun Capital Management first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Elgethun Capital Management held 6,305 shares of AbbVie worth $1.59M as of Q2 2026.
- Elgethun Capital Management bought 142 AbbVie shares in Q2 2026, an estimated $30.6K.
- AbbVie made up 0.22% of Elgethun Capital Management's portfolio in Q2 2026, its #58 holding.
- Elgethun Capital Management first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
- 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Elgethun Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.